Search research articles
Contact Us
Filters
Showing results (261-270 of 416) with videos related to
Page
of 42
Sort By:
Oncology Reports
|
May 17, 2011
Quantitative analysis of colorectal mucosal lesions by autofluorescence endoscopy: discrimination of carcinomas from other lesions
Keiko Arita, Keiichi Mitsuyama, Hiroshi Kawano, et al.
Archives of Virology
|
July 2, 2008
A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy
Kei Ogata, Takahito Kashiwagi, Jun Iwahashi, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|
December 24, 2010
Direct cholangioscopy using a double-balloon enteroscope: choledochojejunostomy with intraductal biliary carcinoma
Yoshinobu Okabe, Kotaro Kuwaki, Hiroshi Kawano, et al.
Journal of Gastroenterology
|
April 14, 2010
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
Kiwamu Okita, Isao Sakaida, Mitsuru Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 17, 2010
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Shigeki Arii, Michio Sata, Michiie Sakamoto, et al.
Oncology Reports
|
April 30, 2010
The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma
Sakae Nagaoka, Takafumi Yoshida, Junji Akiyoshi, et al.
Journal of Medical Virology
|
November 25, 2003
Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy
Reiichiro Kuwahara, Ryukichi Kumashiro, Shiro Murashima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 2, 2007
Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis
Hiroyuki Koga, Tatsuya Ide, Kazuhiko Oho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2012
Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice
Kinya Inoue, Takuji Torimura, Toru Nakamura, et al.
Digestive Diseases and Sciences
|
July 12, 2008
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV
Reiichiro Kuwahara, Ryukichi Kumashiro, Tatsuya Ide, et al.
Page
of 42
Search research articles
Search
Showing results (261-270 of 416) with videos related to
Sort By:
Page
of 42
Oncology Reports
|
May 17, 2011
Quantitative analysis of colorectal mucosal lesions by autofluorescence endoscopy: discrimination of carcinomas from other lesions
Keiko Arita, Keiichi Mitsuyama, Hiroshi Kawano, et al.
Archives of Virology
|
July 2, 2008
A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy
Kei Ogata, Takahito Kashiwagi, Jun Iwahashi, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|
December 24, 2010
Direct cholangioscopy using a double-balloon enteroscope: choledochojejunostomy with intraductal biliary carcinoma
Yoshinobu Okabe, Kotaro Kuwaki, Hiroshi Kawano, et al.
Journal of Gastroenterology
|
April 14, 2010
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
Kiwamu Okita, Isao Sakaida, Mitsuru Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 17, 2010
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Shigeki Arii, Michio Sata, Michiie Sakamoto, et al.
Oncology Reports
|
April 30, 2010
The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma
Sakae Nagaoka, Takafumi Yoshida, Junji Akiyoshi, et al.
Journal of Medical Virology
|
November 25, 2003
Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy
Reiichiro Kuwahara, Ryukichi Kumashiro, Shiro Murashima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 2, 2007
Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis
Hiroyuki Koga, Tatsuya Ide, Kazuhiko Oho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2012
Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice
Kinya Inoue, Takuji Torimura, Toru Nakamura, et al.
Digestive Diseases and Sciences
|
July 12, 2008
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV
Reiichiro Kuwahara, Ryukichi Kumashiro, Tatsuya Ide, et al.
Page
of 42